Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

42 results about "Ventricular stimulation" patented technology

System and method for automatically and adaptively segmenting an atrial blanking period

An implantable stimulation device delivers a stimulation pulse in the ventricular chamber of a patient's heart and automatically adjusts a post-ventricular atrial blanking period. The stimulation device generates a ventricular stimulation pulse to trigger an evoked response, in order to produce a ventricular far-field signal that follows a successfully captured ventricular stimulation pulse. The stimulation device further includes an atrial sense circuit that senses the ventricular far-field signal, and a control system that adaptively segments the post-ventricular atrial blanking period in a post-ventricular atrial blanking period (PVAB) which is fixed in duration, and a variable far-field interval (FFI) window. PVAB is initiated upon the delivery of the ventricular stimulation pulse, such that events sensed outside the segmented post-ventricular atrial blanking (SPVAB) period are presumed to be intrinsic atrial events, and events sensed within the far-field interval window are presumed to be far-field signals. The far-field interval window is preferably centered on a previously sensed far-field R-wave. If an intrinsic ventricular event is sensed, the stimulation device does not initiate the PVAB period but rather sets the FFI window.
Owner:PACESETTER INC

Multi-site cardiac stimulation device and method for detecting retrograde conduction

InactiveUS6862477B1Prevent inappropriate arrhythmia detectionImprove responseHeart stimulatorsMulti siteCardiac pacemaker electrode
An implantable cardiac stimulation device, such as a pacemaker, defibrillator and / or cardioverter, and an associated method that provide cardiac stimulation to at least two ventricular stimulation sites, within a single ventricle or across two ventricles. A high intrinsic atrial rate triggers a retrograde conduction detection routine when a high ventricular stimulation rate is sustained for a predetermined number of cycles during an atrial sensing mode. This routine interrupts concurrent stimulation, and alternates the stimulation output to the different ventricular sites.
Owner:PACESETTER INC

Pacemaker control dependent on natural AV conduction or PVC/VES detection

ActiveUS7072714B2Heart stimulatorsVentricular extrasystolesVentricular contraction
A dual-chamber cardiac pacemaker comprising an atrial detection unit which is adapted to detect electrical signals in the atrium of a heart as atrial sense events, a ventricular detection unit which is adapted to detect electrical signals of a ventricle of the heart as ventricular sense events, a stimulation unit which is adapted at least to trigger the delivery of electrical pulses to the ventricle as ventricular stimulation events, and a control unit which is connected to the atrial and the ventricular detection units and the stimulation unit and adapted to control triggering of the delivery of pulses in dependence on the atrial detection unit and the ventricular detection unit in such a way that pulse delivery to the ventricle is triggered after the expiry of an AV time after detection of an atrial sense or stimulation event if prior to expiry of the AV time no ventricular sense event is detected by the ventricular detection unit, wherein the control unit is further adapted to divide ventricular sense events into at least two categories of which a first category concerns ventricular sense events to be associated with natural stimulus conduction from the atrium to the ventricle while a second category concerns ventricular sense events to be associated with ventricular extrasystoles or premature ventricular contractions (PVC) and control of the cardiac pacemaker is differentiated in accordance with whether a ventricular sense event is or is not associated with the first category, characterized in that for the control of triggering of pulse delivery an AV monitoring interval is provided in such a way that the AV monitoring interval is triggered by each atrial sense event which is outside an atrial refractory time, wherein the cardiac pacemaker is adapted to associate ventricular events occurring within the AV monitoring interval to the first category.
Owner:BIOTRONIK MESS UND THERAPIEGERAETE GMBH & CO

Calculation of the Atrioventricular Delay for an Active Implantable Metal Device

An active implantable medical device including circuits for calculating an atrio ventricular delay (AVD) period. The device is able to detect the atrial and ventricular events; calculate an AVD and to start the AVD on detection of a spontaneous or paced atrial event. The device is able to deliver a low energy ventricular stimulation pulse at the expiration of the AVD in the absence of a detected spontaneous ventricular event. To calculate the AVD, the device uses an acceleration sensor to deliver an endocardiac acceleration (EA) signal representative of the movements produced by the contractions of the atrial cavity; and analyzes the EA signal to identify and isolate in the EA signal a component corresponding to the fourth peak of endocardiac acceleration (PEA4) associated to the atrial activity, and to calculate the AVD based on a parameter of this component.
Owner:SORIN CRM

Multi-site active implantable medical device including a mode of resynchronization of the ventricles

ActiveUS20050131471A1Predetermined timeHeart stimulatorsMulti siteLeft ventricular size
An active implantable medical device comprising circuits for right ventricular, left ventricular, right atrial and eventually left atrial detection, as well as circuits for right and left ventricular stimulation. The device can operate in mode of resynchronization of the ventricular contractions, with an adjustable delay of inter-ventricular stimulation. It includes moreover: circuits for atrial stimulation; circuits able to operate the device in AAI mode with right atrial stimulation and right ventricular detection; circuits for detection of ventricular capture, to determine the detection or the loss of capture after a right ventricular stimulation and a left ventricular stimulation; and of the circuits for mode switching, able to control a switching of mode, from the mode of resynchronization towards AAI mode, in response to the detection of a loss of capture after a right ventricular stimulation or a left ventricular stimulation.
Owner:ELA MEDICAL

Multi-site cardiac stimulation device and method for detecting retrograde conduction

InactiveUS7146215B1Prevent inappropriate arrhythmia detectionImprove responseHeart stimulatorsMulti siteCardiac pacemaker electrode
An implantable cardiac stimulation device, such as a pacemaker, defibrillator and / or cardioverter, and an associated method that provide cardiac stimulation to at least two ventricular stimulation sites, within a single ventricle or across two ventricles. A high intrinsic atrial rate triggers a retrograde conduction detection routine when a high ventricular stimulation rate is sustained for a predetermined number of cycles during an atrial sensing mode. This routine interrupts concurrent stimulation, and alternates the stimulation output to the different ventricular sites.
Owner:PACESETTER INC

Implantable medical device for biventricular stimulation

A heart stimulator for biventricular pacing comprises at least one stimulation pulse generator connected or connectable to a right ventricular or atrial stimulation electrode lead and a left ventricular or atrial electrode lead, respectively. The heart stimulator is adapted to generate right chamber stimulation pulses for a right atrium or ventricle and left chamber stimulation pulses for a left ventricle or atrium. A high rate protection unit connected to said stimulation pulse generator is adapted to trigger, upon any right or left chamber stimulation pulse, a protection time window having a predetermined duration in time and comprising an early part immediately followed by a late part. The protection unit is further adapted to only allow atrial or ventricular stimulation pulses in said early part of said protection time window and to suppress any atrial or ventricular stimulation pulse in said late part.
Owner:BIOTRONIK SE & CO KG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products